Group Interventions for Patients with Cancer and HIV Disease: Part II. Effects on Immune, Endocrine, and Disease Outcomes at Different Phases of Illness
There has been great interest in the potential impact of group interventions on medical outcomes. This article reviews the effects of professionally-led groups on immune activity, neuroendocrine function, and survival among patients with cancer or HIV disease. We examine findings concerning differen...
Gespeichert in:
| Veröffentlicht in: | International journal of group psychotherapy 2004-04, Vol.54 (2), p.203-233 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 233 |
|---|---|
| container_issue | 2 |
| container_start_page | 203 |
| container_title | International journal of group psychotherapy |
| container_volume | 54 |
| creator | Sherman, Allen C. Leszcz, Molyn Mosier, Julie Burlingame, Gary M. Cleary, Trish Ulman, Kathleen Hubbs Simonton, Stephanie Latif, Umaira Strauss, Bernhard Hazelton, Lara |
| description | There has been great interest in the potential impact of group interventions on medical outcomes. This article reviews the effects of professionally-led groups on immune activity, neuroendocrine function, and survival among patients with cancer or HIV disease. We examine findings concerning different types of group services at different phases of illness. Results are mixed, but the most prominent changes in immune and endocrine activity were associated with structured group interventions for patients with early-stage disease. These findings offer provocative illustrations of relevant mind-body interactions, but their clinical importance has yet to be demonstrated empirically. Group interventions have not been tied consistently to improved survival rates for patients with advanced cancer; few studies as yet have focused on survival outcomes among patients with early-stage cancer or HIV disease. |
| doi_str_mv | 10.1521/ijgp.54.2.203.40390 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_15104002</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>623917331</sourcerecordid><originalsourceid>FETCH-LOGICAL-c384t-7df547f81536f6d984e7da70d7a1a359b5c6526bb5bc6c4b573dbef67cd0abfe3</originalsourceid><addsrcrecordid>eNp9kctu1DAUhi1ERYfCEyAhC4kdCXZ8y7CohIahjVSpXQBby_GFZpTYg-1Q9U14XDxMqrLqyrfvO8c6PwBvMKoxa_DHYfdzXzNaN3WDSE0RWaNnYIXXlFRNS_hzsEKoQZVoWnoKXqa0QwgT1vIX4BQzjGh5XYE_FzHMe9j5bONv6_MQfIIuRHij8lDOCd4N-RZulNc2QuUNvOx-wC9DsirZT4WKGXZdDbfOWV3o4GE3TbO3H-DWm6DjcNgevMWB13PWYbIJqlzuihZLG3hzW96K7mA3jt6m9AqcODUm-3pZz8D3r9tvm8vq6vqi23y-qjRpaa6EcYwK12JGuONm3VIrjBLICIUVYeueac4a3ves11zTnglieuu40Aap3llyBt4d6-5j-DXblOUuzNGXlrKMUgjEW1IgcoR0DClF6-Q-DpOK9xIjeQhDHsKQjMpGljDkvzCK9XYpPfeTNY_OMv0CvF8AlbQaXSxTHtJ_HCccCVa48yM3-BLNpO5CHI3M6n4M8UEiT_3kLz0tqNY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>194770683</pqid></control><display><type>article</type><title>Group Interventions for Patients with Cancer and HIV Disease: Part II. Effects on Immune, Endocrine, and Disease Outcomes at Different Phases of Illness</title><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><source>MEDLINE</source><source>Guilford Periodicals Online</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Sherman, Allen C. ; Leszcz, Molyn ; Mosier, Julie ; Burlingame, Gary M. ; Cleary, Trish ; Ulman, Kathleen Hubbs ; Simonton, Stephanie ; Latif, Umaira ; Strauss, Bernhard ; Hazelton, Lara</creator><creatorcontrib>Sherman, Allen C. ; Leszcz, Molyn ; Mosier, Julie ; Burlingame, Gary M. ; Cleary, Trish ; Ulman, Kathleen Hubbs ; Simonton, Stephanie ; Latif, Umaira ; Strauss, Bernhard ; Hazelton, Lara</creatorcontrib><description>There has been great interest in the potential impact of group interventions on medical outcomes. This article reviews the effects of professionally-led groups on immune activity, neuroendocrine function, and survival among patients with cancer or HIV disease. We examine findings concerning different types of group services at different phases of illness. Results are mixed, but the most prominent changes in immune and endocrine activity were associated with structured group interventions for patients with early-stage disease. These findings offer provocative illustrations of relevant mind-body interactions, but their clinical importance has yet to be demonstrated empirically. Group interventions have not been tied consistently to improved survival rates for patients with advanced cancer; few studies as yet have focused on survival outcomes among patients with early-stage cancer or HIV disease.</description><identifier>ISSN: 0020-7284</identifier><identifier>EISSN: 1943-2836</identifier><identifier>DOI: 10.1521/ijgp.54.2.203.40390</identifier><identifier>PMID: 15104002</identifier><identifier>CODEN: IJGPAO</identifier><language>eng</language><publisher>New York, NY: Routledge</publisher><subject>Biological and medical sciences ; Cancer ; CD4 Antigens - immunology ; Clinical outcomes ; Depression - etiology ; Depression - immunology ; Depression - metabolism ; Disease Progression ; Group psychotherapy ; Group therapy ; HIV ; HIV Seropositivity - psychology ; Human immunodeficiency virus ; Humans ; Hypothalamo-Hypophyseal System - physiopathology ; Killer Cells, Natural - immunology ; Medical sciences ; Neoplasms - psychology ; Patients ; Pituitary-Adrenal System - physiopathology ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Psychotherapies. Psychological and clinical counseling ; Psychotherapy ; Treatments</subject><ispartof>International journal of group psychotherapy, 2004-04, Vol.54 (2), p.203-233</ispartof><rights>Guilford Publications Inc. 2004</rights><rights>2004 INIST-CNRS</rights><rights>Copyright Guilford Publications, Inc. Apr 2004</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c384t-7df547f81536f6d984e7da70d7a1a359b5c6526bb5bc6c4b573dbef67cd0abfe3</citedby><cites>FETCH-LOGICAL-c384t-7df547f81536f6d984e7da70d7a1a359b5c6526bb5bc6c4b573dbef67cd0abfe3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3659,12825,27901,27902,30976</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15636075$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15104002$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sherman, Allen C.</creatorcontrib><creatorcontrib>Leszcz, Molyn</creatorcontrib><creatorcontrib>Mosier, Julie</creatorcontrib><creatorcontrib>Burlingame, Gary M.</creatorcontrib><creatorcontrib>Cleary, Trish</creatorcontrib><creatorcontrib>Ulman, Kathleen Hubbs</creatorcontrib><creatorcontrib>Simonton, Stephanie</creatorcontrib><creatorcontrib>Latif, Umaira</creatorcontrib><creatorcontrib>Strauss, Bernhard</creatorcontrib><creatorcontrib>Hazelton, Lara</creatorcontrib><title>Group Interventions for Patients with Cancer and HIV Disease: Part II. Effects on Immune, Endocrine, and Disease Outcomes at Different Phases of Illness</title><title>International journal of group psychotherapy</title><addtitle>Int J Group Psychother</addtitle><description>There has been great interest in the potential impact of group interventions on medical outcomes. This article reviews the effects of professionally-led groups on immune activity, neuroendocrine function, and survival among patients with cancer or HIV disease. We examine findings concerning different types of group services at different phases of illness. Results are mixed, but the most prominent changes in immune and endocrine activity were associated with structured group interventions for patients with early-stage disease. These findings offer provocative illustrations of relevant mind-body interactions, but their clinical importance has yet to be demonstrated empirically. Group interventions have not been tied consistently to improved survival rates for patients with advanced cancer; few studies as yet have focused on survival outcomes among patients with early-stage cancer or HIV disease.</description><subject>Biological and medical sciences</subject><subject>Cancer</subject><subject>CD4 Antigens - immunology</subject><subject>Clinical outcomes</subject><subject>Depression - etiology</subject><subject>Depression - immunology</subject><subject>Depression - metabolism</subject><subject>Disease Progression</subject><subject>Group psychotherapy</subject><subject>Group therapy</subject><subject>HIV</subject><subject>HIV Seropositivity - psychology</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Hypothalamo-Hypophyseal System - physiopathology</subject><subject>Killer Cells, Natural - immunology</subject><subject>Medical sciences</subject><subject>Neoplasms - psychology</subject><subject>Patients</subject><subject>Pituitary-Adrenal System - physiopathology</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Psychotherapies. Psychological and clinical counseling</subject><subject>Psychotherapy</subject><subject>Treatments</subject><issn>0020-7284</issn><issn>1943-2836</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kctu1DAUhi1ERYfCEyAhC4kdCXZ8y7CohIahjVSpXQBby_GFZpTYg-1Q9U14XDxMqrLqyrfvO8c6PwBvMKoxa_DHYfdzXzNaN3WDSE0RWaNnYIXXlFRNS_hzsEKoQZVoWnoKXqa0QwgT1vIX4BQzjGh5XYE_FzHMe9j5bONv6_MQfIIuRHij8lDOCd4N-RZulNc2QuUNvOx-wC9DsirZT4WKGXZdDbfOWV3o4GE3TbO3H-DWm6DjcNgevMWB13PWYbIJqlzuihZLG3hzW96K7mA3jt6m9AqcODUm-3pZz8D3r9tvm8vq6vqi23y-qjRpaa6EcYwK12JGuONm3VIrjBLICIUVYeueac4a3ves11zTnglieuu40Aap3llyBt4d6-5j-DXblOUuzNGXlrKMUgjEW1IgcoR0DClF6-Q-DpOK9xIjeQhDHsKQjMpGljDkvzCK9XYpPfeTNY_OMv0CvF8AlbQaXSxTHtJ_HCccCVa48yM3-BLNpO5CHI3M6n4M8UEiT_3kLz0tqNY</recordid><startdate>20040401</startdate><enddate>20040401</enddate><creator>Sherman, Allen C.</creator><creator>Leszcz, Molyn</creator><creator>Mosier, Julie</creator><creator>Burlingame, Gary M.</creator><creator>Cleary, Trish</creator><creator>Ulman, Kathleen Hubbs</creator><creator>Simonton, Stephanie</creator><creator>Latif, Umaira</creator><creator>Strauss, Bernhard</creator><creator>Hazelton, Lara</creator><general>Routledge</general><general>Guilford</general><general>Taylor & Francis Ltd</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7QJ</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>88J</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HEHIP</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2R</scope><scope>M2S</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope></search><sort><creationdate>20040401</creationdate><title>Group Interventions for Patients with Cancer and HIV Disease: Part II. Effects on Immune, Endocrine, and Disease Outcomes at Different Phases of Illness</title><author>Sherman, Allen C. ; Leszcz, Molyn ; Mosier, Julie ; Burlingame, Gary M. ; Cleary, Trish ; Ulman, Kathleen Hubbs ; Simonton, Stephanie ; Latif, Umaira ; Strauss, Bernhard ; Hazelton, Lara</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c384t-7df547f81536f6d984e7da70d7a1a359b5c6526bb5bc6c4b573dbef67cd0abfe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Biological and medical sciences</topic><topic>Cancer</topic><topic>CD4 Antigens - immunology</topic><topic>Clinical outcomes</topic><topic>Depression - etiology</topic><topic>Depression - immunology</topic><topic>Depression - metabolism</topic><topic>Disease Progression</topic><topic>Group psychotherapy</topic><topic>Group therapy</topic><topic>HIV</topic><topic>HIV Seropositivity - psychology</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Hypothalamo-Hypophyseal System - physiopathology</topic><topic>Killer Cells, Natural - immunology</topic><topic>Medical sciences</topic><topic>Neoplasms - psychology</topic><topic>Patients</topic><topic>Pituitary-Adrenal System - physiopathology</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Psychotherapies. Psychological and clinical counseling</topic><topic>Psychotherapy</topic><topic>Treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sherman, Allen C.</creatorcontrib><creatorcontrib>Leszcz, Molyn</creatorcontrib><creatorcontrib>Mosier, Julie</creatorcontrib><creatorcontrib>Burlingame, Gary M.</creatorcontrib><creatorcontrib>Cleary, Trish</creatorcontrib><creatorcontrib>Ulman, Kathleen Hubbs</creatorcontrib><creatorcontrib>Simonton, Stephanie</creatorcontrib><creatorcontrib>Latif, Umaira</creatorcontrib><creatorcontrib>Strauss, Bernhard</creatorcontrib><creatorcontrib>Hazelton, Lara</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Social Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>Sociology Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Social Science Database</collection><collection>Sociology Database</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><jtitle>International journal of group psychotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sherman, Allen C.</au><au>Leszcz, Molyn</au><au>Mosier, Julie</au><au>Burlingame, Gary M.</au><au>Cleary, Trish</au><au>Ulman, Kathleen Hubbs</au><au>Simonton, Stephanie</au><au>Latif, Umaira</au><au>Strauss, Bernhard</au><au>Hazelton, Lara</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Group Interventions for Patients with Cancer and HIV Disease: Part II. Effects on Immune, Endocrine, and Disease Outcomes at Different Phases of Illness</atitle><jtitle>International journal of group psychotherapy</jtitle><addtitle>Int J Group Psychother</addtitle><date>2004-04-01</date><risdate>2004</risdate><volume>54</volume><issue>2</issue><spage>203</spage><epage>233</epage><pages>203-233</pages><issn>0020-7284</issn><eissn>1943-2836</eissn><coden>IJGPAO</coden><abstract>There has been great interest in the potential impact of group interventions on medical outcomes. This article reviews the effects of professionally-led groups on immune activity, neuroendocrine function, and survival among patients with cancer or HIV disease. We examine findings concerning different types of group services at different phases of illness. Results are mixed, but the most prominent changes in immune and endocrine activity were associated with structured group interventions for patients with early-stage disease. These findings offer provocative illustrations of relevant mind-body interactions, but their clinical importance has yet to be demonstrated empirically. Group interventions have not been tied consistently to improved survival rates for patients with advanced cancer; few studies as yet have focused on survival outcomes among patients with early-stage cancer or HIV disease.</abstract><cop>New York, NY</cop><pub>Routledge</pub><pmid>15104002</pmid><doi>10.1521/ijgp.54.2.203.40390</doi><tpages>31</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0020-7284 |
| ispartof | International journal of group psychotherapy, 2004-04, Vol.54 (2), p.203-233 |
| issn | 0020-7284 1943-2836 |
| language | eng |
| recordid | cdi_pubmed_primary_15104002 |
| source | Applied Social Sciences Index & Abstracts (ASSIA); MEDLINE; Guilford Periodicals Online; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Biological and medical sciences Cancer CD4 Antigens - immunology Clinical outcomes Depression - etiology Depression - immunology Depression - metabolism Disease Progression Group psychotherapy Group therapy HIV HIV Seropositivity - psychology Human immunodeficiency virus Humans Hypothalamo-Hypophyseal System - physiopathology Killer Cells, Natural - immunology Medical sciences Neoplasms - psychology Patients Pituitary-Adrenal System - physiopathology Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychotherapies. Psychological and clinical counseling Psychotherapy Treatments |
| title | Group Interventions for Patients with Cancer and HIV Disease: Part II. Effects on Immune, Endocrine, and Disease Outcomes at Different Phases of Illness |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T21%3A12%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Group%20Interventions%20for%20Patients%20with%20Cancer%20and%20HIV%20Disease:%20Part%20II.%20Effects%20on%20Immune,%20Endocrine,%20and%20Disease%20Outcomes%20at%20Different%20Phases%20of%20Illness&rft.jtitle=International%20journal%20of%20group%20psychotherapy&rft.au=Sherman,%20Allen%20C.&rft.date=2004-04-01&rft.volume=54&rft.issue=2&rft.spage=203&rft.epage=233&rft.pages=203-233&rft.issn=0020-7284&rft.eissn=1943-2836&rft.coden=IJGPAO&rft_id=info:doi/10.1521/ijgp.54.2.203.40390&rft_dat=%3Cproquest_pubme%3E623917331%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=194770683&rft_id=info:pmid/15104002&rfr_iscdi=true |